Publications found:
1,182
Sort by:
MEK Inhibitors Market Size, Share and Growth Outlook 2026: By Target (MEK1, MEK2), By Type, By Application, By Route of Administration, By Dosage, By Distribution Channel, By End User, Companies to 2034.
US$ 3,482.00
The global MEK Inhibitors Market size is forecast to increase from $1.16 Billion in 2026 to $1.86 Billion in 2034 at a CAGR of 6.1% between 2026 and 2034. The MEK Inhibitors market report provides det...
July 2026
190 pages
Oncology Drugs Market Size, Share and Growth Outlook 2026: By Therapy Type (Chemotherapy, Targeted Therapy, Hormonal Therapy, Others), By Modality, By Indication, By Route of Administration, By Distribution Channel, Companies to 2034.
US$ 3,482.00
The global Oncology Drugs Market size is forecast to increase from $191.39 Billion in 2026 to $343.89 Billion in 2034 at a CAGR of 7.6% between 2026 and 2034. The Oncology Drugs market report provides...
July 2026
190 pages
Lung Adenocarcinoma Treatment Market Size, Share and Growth Outlook 2026: By Treatment Type (Targeted Therapy, Immunotherapy, Chemotherapy, Surgery, Radiation Therapy), By Stage of Disease, By End-User, By Distribution Channel, Companies to 2034.
US$ 3,482.00
The global Lung Adenocarcinoma Treatment Market size is forecast to increase from $7.85 Billion in 2026 to $17.66 Billion in 2034 at a CAGR of 10.67% between 2026 and 2034. The Lung Adenocarcinoma Tre...
July 2026
190 pages
Soft Contact Lens Market Size, Share and Growth Outlook 2026: By Material (Silicone Hydrogel, Hydrogel, PMMA, Others), By Design, By Usability, By Application, By Distribution Channel, Companies to 2034.
US$ 3,482.00
The global Soft Contact Lens Market size is forecast to increase from $11.39 Billion in 2026 to $21.46 Billion in 2034 at a CAGR of 8.24% between 2026 and 2034. The Soft Contact Lens market report pro...
July 2026
190 pages
Global Bone Cancer Treatment Market Size Study and Forecast by Drug Class (Cytotoxic Chemotherapy Agents, Tyrosine Kinase Inhibitors (TKIs), Immune Checkpoint Inhibitors, RANKL Inhibitors, IDH Inhibitors, Bisphosphonates, by Cancer Type, by Age Group (Pediatric, Adults), by Therapy, by Route of Administration, by Distribution Channel, and Regional Forecasts 2026–2036
US$ 3,750.00
The Global Bone Cancer Treatment Market, valued at USD 1.32 billion in 2025, is projected to reach USD 2.31 billion by 2036, registering a CAGR of 5.2% during 2026–2036. Bone cancer treatment involves...
July 2026
285 pages
Global Cancer of Unknown Primary (CUP) Therapeutics Market Size Study and Forecast by Drug Class (Platinum Compounds, Taxanes, Immune Checkpoint Inhibitors, Antimetabolites, HER2-Directed ADCs, TRK Inhibitors, BRAF) by Therapy Type, by Age Group, by Route of Administration, by Distribution Channel, and Regional Forecasts 2026–2036
US$ 3,750.00
The Global Cancer of Unknown Primary (CUP) Therapeutics Market, valued at USD 2.25 billion in 2025, is projected to reach USD 4.50 billion by 2036, registering a CAGR of 6.5% during 2026–2036.Cancer o...
July 2026
285 pages
Blood Cancer Therapeutics: Global Markets to 2030
US$ 4,650.00
... , reimbursement and patents. It analyzes prevailing blood cancer treatment guidelines in different geographic regions. The scope of the blood cancer therapeutic market is restricted to three disease areas: leukemia ...
July 2026
214 pages
